Eder Ubaldo Arredondo-Espinoza

7PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Colloid and surface chemistryNutrigenomics and personalised nutritionMolecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 14, 2026
In Vitro Cytotoxic Activity of Coleus hadiensis Methanolic Extract: Metabolic and Transcriptomic Effects in Lung Cancer Cell Line.

Ana L Valdez-Arellanes, Mónica A Ramírez-Cabrera, Eder U Arredondo-Espinoza

|Jul 30, 2025
Spray-Dried Polymeric Microspheres for Lipophilic Drugs: Formulation Design, Physicochemical Characterization, and In Vitro Release Evaluation.

Felipe Nataren-Rodríguez, Jorge Pacheco-Molina, Sandra Leticia Gracia-Vásquez

|Sep 09, 2023
Nutraceuticals and Their Contribution to Preventing Noncommunicable Diseases.

Aurora Garza-Juárez, Esther Pérez-Carrillo, Eder Ubaldo Arredondo-Espinoza

|Mar 29, 2023
Metformin May Alter the Metabolic Reprogramming in Cancer Cells by Disrupting the L-Arginine Metabolism: A Preliminary Computational Study.

Bryan Alejandro Espinosa-Rodriguez, Daniela Treviño-Almaguer, Pilar Carranza-Rosales

|Apr 30, 2021
Bioassay-Guided Identification of the Antiproliferative Compounds of Cissus trifoliata and the Transcriptomic Effect of Resveratrol in Prostate Cancer Pc3 Cells.

Luis Fernando Méndez-López, Pierluigi Caboni, Eder Arredondo-Espinoza

|Mar 06, 2021
Cytotoxic Fractions from Hechtia glomerata Extracts and p-Coumaric Acid as MAPK Inhibitors.

Tommaso Stefani, Antonio Romo-Mancillas, Juan J J Carrizales-Castillo

Pageof 2